profit from every $100 of sales.
$0$100
Ventas
$90.42+0.09% today
+18.7% in 1 year
1-year low $74.901-year high $100.53
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2020 to 2025.
0%20% a year
You pay $190.21 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Ventas sold, what it kept, and what it did with the cash.
Sales went from $4.13 billion in 2022 to $5.83 billion in 2025, with $251 million of profit last year.
SalesProfit
Ventas handed back 86% of the cash it generated last year.
$860M
Free cash flow 2025$1.0B
Bought back its own shares–
Paid as dividends$860M
Cash vs. debt$741M vs. $13.2B
Ventas vs. similar companies
Ventas grows in the middle of these 5 and is priced in the middle for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Ventas | 190.2× · Very expensive | ||
 Welltower | 193.7× · Very expensive | ||
 Omega Healthcare Investors | 25.9× · Fair price | ||
 Healthpeak Properties | 207.4× · Very expensive | ||
 American Healthcare REIT | 196.9× · Very expensive |
AI analysis
An AI analyst reads Ventas's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 3,795 | 3,828 | 4,129 | 4,498 | 4,924 | 5,834 | |
| – | – | 1,846 | 1,937 | 2,097 | 2,414 | |
| – | – | 484 | 416 | 681 | 858 | |
| – | – | 1,620 | 1,949 | 1,937 | 2,271 | |
| 439 | 49 | -47 | -41 | 81 | 251 | |
| 1.17 | 0.13 | -0.12 | -0.10 | 0.19 | 0.54 | |
| – | – | 44.7% | 43.1% | 42.6% | 41.4% | |
| – | – | 11.7% | 9.2% | 13.8% | 14.7% | |
| 11.6% | 1.3% | -1.1% | -0.9% | 1.6% | 4.3% |
Balance sheet
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total assets | 23,929 | 24,718 | 24,158 | 24,725 | 26,187 | 27,592 |
| Cash | 413 | 150 | 123 | 509 | 898 | 741 |
| Total debt | 11,895 | 12,308 | 12,487 | 13,686 | 13,741 | 13,220 |
| Total liabilities | 13,416 | 13,492 | 13,936 | 15,181 | 15,357 | 15,006 |
| 10,180 | 10,854 | 10,153 | 9,488 | 10,771 | 12,527 | |
| 377 | 386 | 403 | 406 | 416 | 463 | |
| – | – | 1.4% | 1.8% | 2.1% | 2.6% | |
| 4.3% | 0.5% | -0.5% | -0.4% | 0.8% | 2.0% |
Cash flow
| In millions of USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 1,450 | 1,026 | 1,120 | 1,120 | 1,330 | 1,647 | |
| – | – | 454 | 643 | 604 | 645 | |
| – | – | 666 | 477 | 726 | 1,002 | |
| Dividends paid | 929 | 687 | 720 | 724 | 740 | 860 |
| – | – | – | – | – | – | |
| 21 | 32 | 31 | 31 | 31 | 39 |
Valuation
- 190.2×
- 123.3×
- –
- 3.7×
- 8.2×
- 47.7×
- 26.5×
- 2.1%
- 0.5%
- 2.2%
Profitability
- 41.4%
- 14.7%
- 4.3%
- 40.0%
- 2.7%
- 2.0%
- 2.1%
- 0.9%
- 3.1%
- –
Growth
- +9.0%
- −14.3%
- +24.6%
- −2.2%
- +4.7%
Financial health
- 5.5×
- 1.06
- 46.0%
- 1.4×
- 0.96
- 0.15
- 0.22
How it ranks in Real Estate
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 27%of 746
Bottom 20%of 752
Bottom 2%of 666
Top 43%of 762
Bottom 27%of 763
What analysts expect
- Average price target
- $93.00
- Range
- $85.00 – $100.00
- 9 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Apr 27, 2026 | 0.12 | 0.12 | −2.4% |
| Feb 5, 2026 | 0.15 | 0.10 | +49.0% |
| Oct 29, 2025 | 0.88 | 0.87 | +1.1% |
| Jul 30, 2025 | 0.87 | 0.85 | +2.4% |
| Apr 30, 2025 | 0.84 | 0.82 | +2.4% |
| Feb 12, 2025 | 0.81 | -0.02 | +4,150.0% |
| Oct 30, 2024 | 0.80 | 0.80 | +0.0% |
| Aug 1, 2024 | 0.80 | 0.79 | +1.3% |
2.2%of the share price, paid each year
On $1,000 invested$22a year at today's yield, before tax
−2.2%2020 to 2025
Raised1 yearin a row, in our data
Paid per share, each year
$3.26 in 2015 → $1.92 in 2025
How safe it looks
342.1% of its profit
Room to growStretchedMore than it earns: 85.8%
News
Ventas Q3 earnings, revenue beat on senior housing organic growthSeeking Alpha · Oct 27, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
2/7Passes 2 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
40No pass
Benjamin Graham
55No pass
Philip Fisher
63Pass
Peter Lynch
79Pass
Joel Greenblatt
41No pass
Charlie Munger
44No pass
Terry Smith
35No pass
Questions about Ventas
Is Ventas a good stock to buy?
A business with weak numbers, priced as if everything goes right. 2 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Ventas AI analysis
What does Ventas do?
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. It is in REIT - Healthcare Facilities, based in Chicago, IL, United States, with 542 employees.
Does Ventas pay a dividend?
Yes. At today's price the dividend is 2.2% a year. In 2025 it paid out $860 million in dividends.
Is Ventas stock halal?
Yes. Ventas passes our halal screen: its business is permitted and its debt is 28% of its market value, under the 30% limit. How we check
How has Ventas stock done over the past year?
Up 18.7% over the past twelve months, to $90.42. It traded between $74.90 and $100.53 and is 10.1% below its high.
Who are Ventas's competitors?
The largest listed companies in the same industry are Welltower, Omega Healthcare Investors, Healthpeak Properties and American Healthcare REIT. The peers table on this page compares their profit, growth and price with Ventas's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.